What post-procedure barrier emollient is recommended to soothe micro-puncture sites in the vulvar vestibule immediately after injection
Quality control Source material Traceability Women’s Health Clinic FAQ How should public content discuss skin-soothing aftercare without recommending a specific post-procedure product Source and purification questions…
What specific clinical screening protocol evaluates fish or seafood protein allergy risks prior to injecting salmon-derived polynucleotides
Quality control Source material Traceability Women’s Health Clinic FAQ What specific clinical screening protocol evaluates fish or seafood protein allergy risks prior to injecting salmon-derived polynucleotides…
How does the removal of double-stranded DNA immunogenic epitopes prevent human anti-DNA antibody generation during polynucleotide therapy
Quality control Source material Traceability Women’s Health Clinic FAQ How does the removal of double-stranded DNA immunogenic epitopes prevent human anti-DNA antibody generation during polynucleotide therapy…
What is the oncological safety profile of polynucleotides in patients with a history of hormone-receptor-positive breast or gynaecological cancers
Quality control Source material Traceability Women’s Health Clinic FAQ What is the oncological safety profile of polynucleotides in patients with a history of hormone-receptor-positive breast or…
What is the clinical management protocol if a patient develops transient papules or mild oedema at the sub-mucosal injection sites
Breakdown Timeline No protocol Women’s Health Clinic FAQ What is the clinical management protocol if a patient develops transient papules or mild ooedema at the sub-mucosal…
How do clinicians screen for active vulvovaginal infections (yeast, BV, STIs) before proceeding with intimate polynucleotide injections
Inflammation Pain pathways Specialist review Women’s Health Clinic FAQ How do clinicians screen for active vulvovaginal infections (yeast, BV, STIs) before proceeding with intimate polynucleotide injections…
What is the safety profile of polynucleotides when injected into tissue containing previously placed synthetic pelvic mesh or slings
Matrix biology Barrier function Realistic claims Women’s Health Clinic FAQ What is the safety profile of polynucleotides when injected into tissue containing previously placed synthetic pelvic…
Can polynucleotides be safely administered to patients taking systemic immunosuppressive or anti-rheumatic biologic therapies
Inflammation Pain pathways Specialist review Women’s Health Clinic FAQ Can polynucleotides be safely administered to patients taking systemic immunosuppressive or anti-rheumatic biologic therapies Inflammation and nerve-density…
What precautions are necessary when administering polynucleotides to patients with active autoimmune diseases like systemic lupus erythematosus
Inflammation Pain pathways Specialist review Women’s Health Clinic FAQ What precautions are necessary when administering polynucleotides to patients with active autoimmune diseases like systemic lupus erythematosus…
What is the risk of localised micro-haematoma or purpura formation when injecting vascularly fragile atrophic mucosa with polynucleotides
Oxidative stress Microvascular Cautious biology Women’s Health Clinic FAQ What is the risk of localised micro-haematoma or purpura formation when injecting vascularly fragile atrophic mucosa with…
Still not sure where to start?
Browse the wider treatment pages or book a free consultation so we can help you find the most relevant next step.
